| Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC | |
| Ge, Chunlei; Li, Ruilei; Song, Haifeng; Geng, Tao; Yang, Jinyan; Tan, Qinghua; Song, Linfeng; Wang, Ying; Xue, Yuanbo; Li, Zhen | |
| 刊名 | BMC CANCER
 |
| 2017 | |
| 卷号 | 17 |
| 关键词 | Modified-DCvaccine Non-small cell lung cancer (NSCLC) Phase I clinical trial |
| ISSN号 | 1471-2407 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3424419 |
| 专题 | 昆明医科大学 |
| 推荐引用方式 GB/T 7714 | Ge, Chunlei,Li, Ruilei,Song, Haifeng,et al. Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC[J]. BMC CANCER,2017,17. |
| APA | Ge, Chunlei.,Li, Ruilei.,Song, Haifeng.,Geng, Tao.,Yang, Jinyan.,...&Song, Xin.(2017).Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.BMC CANCER,17. |
| MLA | Ge, Chunlei,et al."Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC".BMC CANCER 17(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论